Meta-analysis of short-term high versus low doses of atorvastatin preventing contrast-induced acute kidney injury in patients undergoing coronary angiography/percutaneous coronary intervention
Author:
Affiliation:
1. Department of Cardiovascular Surgery; Shenyang Northern Hospital; Shenyang China
2. Department of Air Force Service; The Chinese People's Liberation Army 463 Hospital; Shenyang China
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Reference42 articles.
1. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC);Hamm;Eur Heart J,2011
2. Outcomes of contrast-induced nephropathy: experience in patients undergoing cardiovascular intervention;McCullough;Catheter Cardiovasc Interv,2006
3. Hospital-acquired renal insufficiency;Nash;Am J Kidney Dis,2002
4. Renal failure after percutaneous coronary intervention is associated with high mortality;Gupta;Catheter Cardiovasc Interv,2005
5. Impact of acute renal failure following percutaneous coronary intervention on long-term mortality;Roghi;J Cardiovasc Med (Hagerstown),2008
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The atorvastatin effects on the prevention of contrast-induced acute kidney injury during computed tomography with contrast media;Terapevticheskii arkhiv;2022-10-24
2. The preventive effects of different doses of atorvastatin on contrast‐induced acute kidney injury after CT perfusion;Journal of Clinical Laboratory Analysis;2022-05-17
3. The atorvastatin effects on the prevention of contrast-induced acute kidney injury during computed tomography with contrast media;TERAPEVT ARKH;2022
4. Association of in-hospital intensive statins dosage and death in arteriosclerotic cardiovascular disease with percutaneous coronary intervention: insights of multicentre cohort from China;European Journal of Clinical Pharmacology;2020-07-22
5. Pharmacologic Prophylaxis of Contrast-Induced Nephropathy;Interventional Cardiology Clinics;2020-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3